BIOLINERX LTD-SPONS ADR (BLRX)
US09071M2052 - ADR
BIOLINERX LTD-SPONS ADR
NASDAQ:BLRX (11/21/2024, 5:12:52 PM)
After market: 0.3333 +0.01 (+3.09%)0.3233
-0.22 (-40.7%)
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Company Info
BIOLINERX LTD-SPONS ADR
Modi'in Technology Park, 2 HaMa'ayan Street
Modiin 7177871
P: 97286429100
CEO: Philip A. Serlin
Employees: 79
Website: https://www.biolinerx.com/
BLRX News
3 hours ago - ChartmillThursday's session: top gainers and losersWhat's going on in today's session
5 hours ago - ChartmillThursday's session: top gainers and losersLooking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
7 hours ago - ChartmillThursday's session: gap up and gap down stocksLet's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
9 hours ago - ChartmillGet insights into the top gainers and losers of Thursday's pre-market session.Get insights into the top gainers and losers of Thursday's pre-market session.
11 hours ago - BioLineRx Ltd.BioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.– BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as...
a day ago - BioLineRx Ltd.BioLineRx to Report Third Quarter 2024 Results on November 25, 2024/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...
BLRX Twits
Here you can normally see the latest stock twits on BLRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
